News Release

视网膜疾病的基因疗法

Peer-Reviewed Publication

Proceedings of the National Academy of Sciences

Soluble CX3CL1 Gene Therapy

image: Soluble CX3CL1 gene therapy preserves cones in the central retina of retinitis pigmentosa mouse models. view more 

Credit: Sean K. Wang

一项关于可导致视杆细胞和视锥细胞死亡且导致人类失明的退行性眼病色素性视网膜炎的研究发现,注射了携带有CX3CL1 基因的一种可溶形式的病毒载体的小鼠,表现出了视锥细胞存活延长,以及改善的视觉敏锐度,尽管构成其基础的突变导致了该病,这项结果提示,使用CX3CL1 基因的疗法可能有希望在退行性疾病中保存视网膜细胞。

###


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.